Print  |  Close

Study of Long-Term Follow-Up in Patients Who Have Participated in Children's Oncology Group Studies

Active: Yes
Cancer Type: Multiple Primaries NCT ID: NCT00736749
Trial Phases: Protocol IDs: COG-ALTE05N1 (primary)
ALTE05N1
Eligibility: Not specified, Male and Female Study Type: Natural history/Epidemiology
Study Sponsor: Children's Oncology Group
NCI Full Details: http://clinicaltrials.gov/ct/show/NCT00736749

Summary

Rationale

Developing a way to track patients enrolled in Children's Oncology Group studies will help doctors gather long-term follow-up(FAH-loh-up)

Monitoring a person's health over time after treatment. This includes keeping track of the health of people who participate in a clinical study or clinical trial for a period of time, both during the study and after the study ends. information and may help the study of cancer(KAN-ser)

A term for diseases in which abnormal cells divide without control and can invade nearby tissues. Cancer cells can also spread to other parts of the body through the blood and lymph systems. There are several main types of cancer. Carcinoma is a cancer that begins in the skin or in tissues that line or cover internal organs. Sarcoma is a cancer that begins in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue. Leukemia is a cancer that starts in blood-forming tissue such as the bone marrow, and causes large numbers of abnormal blood cells to be produced and enter the blood. Lymphoma and multiple myeloma are cancers that begin in the cells of the immune system. Central nervous system cancers are cancers that begin in the tissues of the brain and spinal cord. Also called malignancy. in the future.

Purpose

This clinical trial(KLIH-nih-kul TRY-ul)

A type of research study that tests how well new medical approaches work in people. These studies test new methods of screening, prevention, diagnosis, or treatment of a disease. Also called clinical study. is studying long-term follow-up in patients who are or have participated in Children's Oncology Group studies.

Objectives

  1. To develop a mechanism for tracking and retaining patients enrolled on COG protocols.
  2. To maintain regular, lifetime contact with patients in order to obtain current identification and contact information, and self/parent-reported health status.
  3. To locate patients who are lost-to-follow-up for COG (or Legacy Group) protocols targeted for follow-up by the Long-Term Follow-Up Center (LTFC).
  4. To provide current patient contact information and self/parent-reported health status updates to the COG Statistics and Data Center (SDC) and to each patient’s COG institution.
  5. To facilitate collection of protocol-specific outcome data through collaboration with the COG Late Effects Committee, the SDC, and the member institutions.
  6. To collect cumulative therapeutic exposure data (via therapeutic summaries completed online by treating institutions) on patients completing active therapy.

Treatment Sites in Georgia

Aflac Cancer and Blood Disorders Center of Children’s at Egleston
1405 Clifton Road NE
3rd Floor
Atlanta, GA 30322
404-785-0853
www.choa.org

Study Coordinator:
Sindy Midoro
Doctors:


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
5455 Meridian Mark Road
Suite 400
Atlanta, GA 30342
404-785-2215
www.choa.org

Study Coordinator:
Sindy Midoro
Doctors:

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.